ClinicalTrials.gov record
Recruiting Phase 1 Interventional

A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

ClinicalTrials.gov ID: NCT07148089

Public ClinicalTrials.gov record NCT07148089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1b, Multicenter, Open-Label, Dose Finding Study to Investigate the Safety and Tolerability of a Single Intravenous Dose of SGT-501 in Patients With Catecholaminergic Polymorphic Ventricular Tachycardia

Study identification

NCT ID
NCT07148089
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 1
Lead sponsor
Solid Biosciences Inc.
Industry
Enrollment
18 participants

Conditions and interventions

Interventions

  • SGT-501 Drug

Drug

Eligibility (public fields only)

Age range
7 Years and older
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 22, 2026
Primary completion
May 31, 2027
Completion
Apr 30, 2031
Last update posted
Mar 26, 2026

2026 – 2031

United States locations

U.S. sites
4
U.S. states
4
U.S. cities
4
Facility City State ZIP Site status
Boston Children's Hospital Boston Massachusetts 02459 Recruiting
Mayo Clinic Rochester Minnesota 55905 Recruiting
Cleveland Clinic Cleveland Ohio 44195 Recruiting
University of Pennsylvania Philadelphia Pennsylvania 19104 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07148089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 26, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07148089 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →